vs
Side-by-side financial comparison of Vita Coco Company, Inc. (COCO) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
Vita Coco Company, Inc. is the larger business by last-quarter revenue ($179.8M vs $151.7M, roughly 1.2× Nutex Health, Inc.). Vita Coco Company, Inc. runs the higher net margin — 17.0% vs 7.8%, a 9.2% gap on every dollar of revenue. On growth, Vita Coco Company, Inc. posted the faster year-over-year revenue change (37.3% vs -41.1%). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 11.7%).
The Vita Coco Company, doing business simply as Vita Coco, is an American beverage company which mainly sells coconut water. The largest brand globally in coconut/plant waters, Vita Coco has operations in 31 countries as of 2016. It is a benefit corporation. The company is owned by All Market Inc.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
COCO vs NUTX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $179.8M | $151.7M |
| Net Profit | $30.5M | $11.8M |
| Gross Margin | 39.9% | 30.4% |
| Operating Margin | 18.7% | 20.4% |
| Net Margin | 17.0% | 7.8% |
| Revenue YoY | 37.3% | -41.1% |
| Net Profit YoY | 61.4% | -80.8% |
| EPS (diluted) | $0.50 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $179.8M | — | ||
| Q4 25 | $127.8M | $151.7M | ||
| Q3 25 | $182.3M | $267.8M | ||
| Q2 25 | $168.8M | $244.0M | ||
| Q1 25 | $130.9M | $211.8M | ||
| Q4 24 | $127.3M | $257.6M | ||
| Q3 24 | $132.9M | $78.8M | ||
| Q2 24 | $144.1M | $76.1M |
| Q1 26 | $30.5M | — | ||
| Q4 25 | $5.5M | $11.8M | ||
| Q3 25 | $24.0M | $55.4M | ||
| Q2 25 | $22.9M | $-17.7M | ||
| Q1 25 | $18.9M | $21.2M | ||
| Q4 24 | $3.4M | $61.6M | ||
| Q3 24 | $19.3M | $-8.8M | ||
| Q2 24 | $19.1M | $-364.0K |
| Q1 26 | 39.9% | — | ||
| Q4 25 | 34.9% | 30.4% | ||
| Q3 25 | 37.7% | 57.8% | ||
| Q2 25 | 36.3% | 51.2% | ||
| Q1 25 | 36.7% | 55.9% | ||
| Q4 24 | 32.5% | 55.0% | ||
| Q3 24 | 38.8% | 27.8% | ||
| Q2 24 | 40.8% | 29.7% |
| Q1 26 | 18.7% | — | ||
| Q4 25 | 8.0% | 20.4% | ||
| Q3 25 | 15.3% | 48.7% | ||
| Q2 25 | 14.9% | 13.8% | ||
| Q1 25 | 14.7% | 38.1% | ||
| Q4 24 | 3.4% | 44.4% | ||
| Q3 24 | 15.5% | 12.3% | ||
| Q2 24 | 20.8% | 7.0% |
| Q1 26 | 17.0% | — | ||
| Q4 25 | 4.3% | 7.8% | ||
| Q3 25 | 13.2% | 20.7% | ||
| Q2 25 | 13.6% | -7.3% | ||
| Q1 25 | 14.4% | 10.0% | ||
| Q4 24 | 2.6% | 23.9% | ||
| Q3 24 | 14.5% | -11.2% | ||
| Q2 24 | 13.2% | -0.5% |
| Q1 26 | $0.50 | — | ||
| Q4 25 | $0.10 | $2.34 | ||
| Q3 25 | $0.40 | $7.76 | ||
| Q2 25 | $0.38 | $-2.95 | ||
| Q1 25 | $0.31 | $3.33 | ||
| Q4 24 | $0.06 | $11.56 | ||
| Q3 24 | $0.32 | $-1.72 | ||
| Q2 24 | $0.32 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $201.9M | $185.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $352.2M | $329.4M |
| Total Assets | $488.3M | $918.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $201.9M | — | ||
| Q4 25 | $196.9M | $185.6M | ||
| Q3 25 | $203.7M | $166.0M | ||
| Q2 25 | $167.0M | $96.7M | ||
| Q1 25 | $153.6M | $84.7M | ||
| Q4 24 | $164.7M | $40.6M | ||
| Q3 24 | $156.7M | $46.9M | ||
| Q2 24 | $150.1M | $40.8M |
| Q1 26 | $352.2M | — | ||
| Q4 25 | $331.5M | $329.4M | ||
| Q3 25 | $323.7M | $317.2M | ||
| Q2 25 | $296.9M | $235.3M | ||
| Q1 25 | $277.9M | $176.9M | ||
| Q4 24 | $258.8M | $132.4M | ||
| Q3 24 | $252.1M | $60.4M | ||
| Q2 24 | $232.0M | $62.7M |
| Q1 26 | $488.3M | — | ||
| Q4 25 | $461.2M | $918.5M | ||
| Q3 25 | $461.3M | $964.5M | ||
| Q2 25 | $421.1M | $841.0M | ||
| Q1 25 | $384.0M | $761.9M | ||
| Q4 24 | $362.4M | $655.3M | ||
| Q3 24 | $353.1M | $438.5M | ||
| Q2 24 | $323.0M | $422.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $70.4M |
| Free Cash FlowOCF − Capex | — | $69.0M |
| FCF MarginFCF / Revenue | — | 45.5% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | — | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | — | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-3.9M | $70.4M | ||
| Q3 25 | $39.1M | $99.5M | ||
| Q2 25 | $21.8M | $27.3M | ||
| Q1 25 | $-9.8M | $51.0M | ||
| Q4 24 | $6.9M | $54.0K | ||
| Q3 24 | $9.3M | $6.8M | ||
| Q2 24 | $26.9M | $13.3M |
| Q1 26 | — | — | ||
| Q4 25 | $-7.1M | $69.0M | ||
| Q3 25 | $35.6M | $99.2M | ||
| Q2 25 | $20.9M | $26.5M | ||
| Q1 25 | $-10.4M | $50.9M | ||
| Q4 24 | $6.8M | $-341.0K | ||
| Q3 24 | $8.9M | $6.2M | ||
| Q2 24 | $26.6M | $12.7M |
| Q1 26 | — | — | ||
| Q4 25 | -5.6% | 45.5% | ||
| Q3 25 | 19.6% | 37.0% | ||
| Q2 25 | 12.4% | 10.9% | ||
| Q1 25 | -7.9% | 24.0% | ||
| Q4 24 | 5.3% | -0.1% | ||
| Q3 24 | 6.7% | 7.8% | ||
| Q2 24 | 18.5% | 16.7% |
| Q1 26 | — | — | ||
| Q4 25 | 2.5% | 0.9% | ||
| Q3 25 | 1.9% | 0.1% | ||
| Q2 25 | 0.6% | 0.3% | ||
| Q1 25 | 0.4% | 0.0% | ||
| Q4 24 | 0.1% | 0.2% | ||
| Q3 24 | 0.3% | 0.8% | ||
| Q2 24 | 0.2% | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | -0.70× | 5.95× | ||
| Q3 25 | 1.63× | 1.80× | ||
| Q2 25 | 0.95× | — | ||
| Q1 25 | -0.52× | 2.40× | ||
| Q4 24 | 2.05× | 0.00× | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 1.41× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COCO
| Subtotal | $148.2M | 82% |
| Private Label | $24.4M | 14% |
| Other | $7.2M | 4% |
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
